Pharmaceutical Manufacturing and Processing Equipment Market Size, Share, Growth, and Industry Analysis by Type (API Equipment, and Finished Product Processing Equipment) By Application (Tablets, Capsules, Injectable, Powders, Sprays, and Others) Regional Forecast From 2024 To 2032

Updated On: 08 July 2024

Pharmaceutical Manufacturing and Processing Equipment Market Report Overview

• 
• PDF to learn more about this report

The global pharmaceutical manufacturing and processing equipment market size is expected to be worth USD 50000 million in 2022 and is projected to touch USD 99868.38 million by 2032, exhibiting a CAGR of 6.5% during the forecast period. In the market study, our analysts have considered pharmaceutical manufacturing and processing equipment players such as Syntegon, IMA, GEA, Truking, Uhlmann, Marchesini, Tofflon, and Glatt, etc. 

In the pharmaceutical industry, chemical materials are manufactured, extracted, processed, purified, and packaged as medications for humans or animals. The manufacturing of pharmaceuticals is generally carried out in batches. In order to ensure the safety and efficacy of drug products, the equipment must be continuously maintained and calibrated. The storage conditions for some raw materials and finished products are very specific. Cost-intensive processes are also involved in the process. There is a great deal of regulation and control in the pharmaceutical manufacturing industry. Every step of the pharmaceutical manufacturing process involves pharmaceutical manufacturing equipment, and almost every process can be automated.

Pharmaceuticals have the strictest quality requirements and manufacturing guidelines. Good manufacturing practice (GMP) is therefore essential for pharmaceutical manufacturing equipment. A range of pharmaceutical manufacturing equipment is available, including capsule filling machines, x-ray inspection systems, and spray drying accessories. It is possible to automate almost every aspect of the manufacturing and formulation development process in order to ensure precision. Each step of the pharmaceutical manufacturing process involves a piece of pharmaceutical manufacturing equipment.

COVID-19 Impact: Halt on Machinery and Equipment to Hamper Market 

The global COVID-19 pandemic has been unprecedented and staggering, with the Pharmaceutical Manufacturing and Processing Equipment Market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels.

In the pharmaceutical manufacturing and processing equipment market, the COVID-19 pandemic has had a positive impact. Therapeutics for combating COVID-19 were in high demand due to the COVID-19 pandemic. As a result of the significant demand for vaccines and medicines for COVID-19, several pharmaceutical companies are expanding their manufacturing facilities. In addition to increasing demand for COVID-19 therapies and vaccines, this strategy is expected to increase the demand for new equipment for processing and packing. Investing around the globe has been drawn to the pharmaceutical industry by the sudden upsurge in all sectors. In response to the pandemic situation, pharmaceutical manufacturers have reoriented their strategies. As a result of COVID-19, pharmaceutical manufacturing had slowed in various countries due to disruptions in the supply chain. In order to reduce the dependence on imports, various public organizations have increased domestic pharmaceutical production.

Latest Trends

"Increasing Demand for Pharmaceutical Drugs to Drive the Market"

It is expected that chronic diseases will increase drug demand in the near future, boosting the growth of the pharmaceutical manufacturing and processing equipment market. In addition, new drug and biological product launches, acquisitions, collaborations, and regional expansions are some of the strategies to maintain market stability.

The growth of government funding as well as advancements in medical technology will contribute to the expansion of the active pharmaceutical ingredient (API) market. The active pharmaceutical ingredient (API) market will also grow due to high disposable income, rising seizures, and changing lifestyles.

Pharmaceutical Manufacturing and Processing Equipment Market Segmentations

• 
• PDF to learn more about this report

•  By Type

The market is classified into API equipment, and finished product processing equipment based on type. The API equipment segment will lead the pharmaceutical manufacturing and processing equipment market share throughout the forecast period.

• By Application

The market is classified into tablets, capsules, injectable, powders, sprays, and others on the basis of application. The tablets segment will lead the pharmaceutical manufacturing and processing equipment market share throughout the forecast period.

Driving Factors

"Rise in Chronic Illness Across the Globe to Drive the Market Growth"

Due to the aging population, sedentary lifestyles, and urbanization, chronic diseases are increasing rapidly around the world. The market for therapeutic drugs is growing at an ever-increasing rate because of this. As chronic diseases become more complex and more common, the demand for innovative drugs, including biologic drugs, increases. Growth in the market will be driven by increasing demand for biologics and biosimilars over the forecast period. Developing countries are increasingly importing raw pharmaceutical ingredients to develop highly-advanced biopharmaceuticals. Active pharmaceutical ingredients market growth is likely to be driven by pharmaceutical firms' increasing investments in research and development activities for the introduction of innovative drugs, and The pharmaceutical manufacturing and processing equipment.

"Increasing R&D Activities to Drive the Market"

The pharmaceutical manufacturing and processing equipment market is expected to benefit from improved R&D and rapid developments in the global pharmaceutical industry. Globally, pharmaceutical R&D investments have increased significantly, according to the IFPMA. For R&D and manufacturing services, drug manufacturers have increasingly turned to external service providers. Pharmaceutical R&D spending and domestic pharmaceutical manufacturing growth in several countries such as China, India, Malaysia, Indonesia, and UAE present significant growth opportunities.

Restraining Factors

"Difficulty in Cleaning the Pharmaceutical Manufacturing Equipments to Restrain the Market"

The task of cleaning pharmaceutical processing equipment can be challenging. Methods of cleaning, soils present, manufacturing equipment, surfaces to be cleaned, cleaning detergent, temperature, and type of manufacturing equipment should all be considered when setting up a cleaning procedure.

Pharmaceutical Manufacturing and Processing Equipment Market Regional Insights

• 
• PDF to learn more about this report

"North America to Dominate the Market Owing to Well-Established Healthcare Infrastructure"

North America's dominance can be explained by the prevalence of pharmaceutical counterfeiting in the region and the focus of key players on improving operational efficiency. In North America, active pharmaceutical ingredients (APIs) dominate the market due to high healthcare expenditures and a well-established healthcare infrastructure. Since API is a type of pharmaceutical manufacturing and processing equipment, it thereby drives the pharmaceutical manufacturing and processing equipment market growth. Cancer and other lifestyle-induced diseases are also driving R&D, which boosts the market.

The rising demand for products in Asia is causing key players to relocate their production units to emerging markets in Asia Pacific as a result of increasing pricing pressure. During the forecast period, this factor is expected to boost the market in Asia Pacific. As a result of the high volume of pharmaceuticals produced and consumed in Asia-Pacific countries, the growing demand for generics, the booming contract manufacturing industry, and favorable government policies intended to boost domestic pharmaceutical production, pharmaceutical processing and packaging equipment is expected to become increasingly popular. Asia-Pacific countries are increasing their domestic pharmaceutical production in order to reduce their dependence on imports. As an example, the Chinese government's Made in China initiative emphasizes domestic manufacturing as well. Asia-Pacific market is expected to benefit from such programs.

Key Industry Players

"Leading Players Adopt Acquisition Strategies to Stay Competitive "

Several players in the market are using acquisition strategies to build their business portfolios and strengthen their market position. In addition, partnerships and collaborations are among the common strategies adopted by companies. Key market players are making R&D investments to bring advanced technologies and solutions to the pharmaceutical manufacturing and processing equipment market.

List of Market Players Profiled

• Syntegon (Germany)
• IMA (Italy)
• GEA (Germany)
• Truking (China)
• Uhlmann (Germany)
• Marchesini (Italy)
• Tofflon (China)
• Glatt  (Germany)
• Bausch + Stroebel (U.S.)
• ACG (India)
• Thermo Fisher (U.S.)
• Sartorius (Germany)
• Agilent Technologies (U.S.)
• L.B. Bohle (Germany)
• Fette (China)
• KORSCH (Germany)
• Coperion (Germany)
• Bruker (U.S.)
• Danaher Corp (U.S.)
• Shimadzu (Japan)
• NETZSCH (Germany)
• Mettler-Toledo (U.S.)
• Gardner Denver (U.S.)
• CEIA (U.S.)
• Anritsu (Japan)
• Gericke (U.S.)
• AERZEN (Germany)
• O'Hara Technologies Inc (Canada)

REPORT COVERAGE

In the report, factors affecting the market from both demand and supply are evaluated and market dynamics during the forecast period are also forecasted. Also included in the report is a comprehensive PEST analysis of countries, which assesses the governmental, financial, and shared factors influencing their markets. Apart from all of these, the report also provides drivers, restraints, opportunities, and future trends.